Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-02

Clinical Trial Update: Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study [NA]

View source ↗

Summary

An open-label randomized controlled study evaluating the efficacy and mechanism of fecal microbiota transplantation for inflammatory bowel disease, including Cr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis), Fecal Microbiota Transplantation | NA | Status: ACTIVE_NOT_RECRUITING